Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,460 | 1,490 | 09:00 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Intelligent Bio Solutions expands drug screening in Scandinavia | 1 | Investing.com | ||
Mi | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia | 4 | GlobeNewswire (USA) | ||
18.06. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion | 6 | GlobeNewswire (USA) | ||
18.06. | EXCLUSIVE: Intelligent Bio's Fingerprint Drug Testing Gains Momentum With New Australian Rollout | 5 | Benzinga.com | ||
16.06. | INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach | 3 | Zacks | ||
11.06. | INBS fingerprint drug screening system deployed in over 50 US locations | 3 | Investing.com | ||
INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln | |||||
11.06. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing | 108 | GlobeNewswire (Europe) | SMARTOX has deployed over 50 of INBS' Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues... ► Artikel lesen | |
11.06. | EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing | 1 | Benzinga.com | ||
30.05. | INTELLIGENT BIO SOLUTIONS INC. - S-8, Securities to be offered to employees in employee benefit plans | 14 | SEC Filings | ||
19.05. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment | 8 | GlobeNewswire (USA) | ||
15.05. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing | 4 | GlobeNewswire (USA) | ||
13.05. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 1 | SEC Filings | ||
13.05. | Intelligent Bio Solutions GAAP EPS of -$0.44, revenue of $0.73M | 1 | Seeking Alpha | ||
13.05. | INTELLIGENT BIO SOLUTIONS INC. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
13.05. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements | 677 | GlobeNewswire (Europe) | 20% sequential quarterly revenue growth and 91% year-over-year quarterly gross profit growth Continued momentum from recurring higher-margin cartridge sales now reaching 58% of total sales for the... ► Artikel lesen | |
13.05. | EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91% | 4 | Benzinga.com | ||
07.05. | Ex-INBS boss Michael Fingleton was 'nodding through' top-up loans to certain clients, High Court told | 4 | BreakingNews.ie | ||
06.05. | Civil case against former INBS boss Michael Fingleton begins in High Court | 3 | BreakingNews.ie | ||
27.03. | Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win | 5 | Zacks | ||
27.03. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra | 252 | GlobeNewswire (Europe) | INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 67,85 | +2,03 % | Leichte Zugewinne bei der Eckert&Ziegler-Aktie (65,60 €) | Die Eckert&Ziegler-Aktie notiert heute etwas fester. Das Wertpapier kostete zuletzt 65,60 Euro. Eine Verteuerung in Höhe von 1,75 Euro erfreut derzeit die Aktionäre von Eckert&Ziegler. Zur Stunde kostet... ► Artikel lesen | |
DRAEGERWERK | 67,10 | +0,15 % | Dräger-Aktie legt um 0,15 Prozent zu (67,10 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Dräger zur Stunde im Plus. Der jüngste Kurs betrug 67,10 Euro. Das Wertpapier von Dräger verzeichnet aktuell ein Kursplus von 0,15 Prozent. Es... ► Artikel lesen | |
TELADOC HEALTH | 7,160 | -0,28 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace) | ||
ROKU | 73,28 | -1,32 % | This 30-second fix made my Roku TV run like new again (and why it works) | ||
HIMS & HERS HEALTH | 42,410 | +0,43 % | Kein Wegovy mehr: Novo Nordisk bricht Partnerschaft: Hims & Hers-Aktie fällt ins Bodenlose! | © Foto: Christian Schultz/dpaNovo Nordisk bricht mit Hims & Hers: Beide Aktien fallen drastisch, wobei der Telemedizinanbieter aus den USA den Kürzeren zieht.Tiefschlag für die Anteilsscheine von Hims... ► Artikel lesen | |
BICO GROUP | 3,210 | -0,25 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
SERNOVA BIOTHERAPEUTICS | 0,109 | +3,81 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
GERATHERM MEDICAL | 3,160 | -3,66 % | Geratherm Medical AG: GJ24 war herausfordernd, vorsichtige Prognose für GJ25; mwb research bekräftigt KAUFEN | Die Ergebnisse von Geratherm für das Geschäftsjahr 2024 zeigten einen Umsatzrückgang von 33% auf 14,0?Mio.?EUR, was in erster Linie auf deutliche Rückgänge in den Bereichen Healthcare Diagnostics und... ► Artikel lesen | |
SYNLAB | 12,900 | +0,70 % | Synlab Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
ALIGN TECHNOLOGY | 159,75 | -0,81 % | Reasons to Add Align Technology Stock to Your Portfolio Now | ||
NUGEN MEDICAL DEVICES | 0,033 | -5,75 % | NuGen Medical Devices - Lillys Geschichte: Ein Teenager aus Nordkanada… | ||
PLUS THERAPEUTICS | 0,318 | -13,37 % | Plus Therapeutics Expects Meaningful Revenue Contributions From CNSide Diagnostics In 2026 | WASHINGTON (dpa-AFX) - Plus Therapeutics, Inc. (PSTV), a clinical-stage pharmaceutical company, expects the revenue contributions of CNSide Diagnostics, LLC to 'become meaningful' in fiscal... ► Artikel lesen | |
HEALWELL AI | 0,850 | -0,53 % | HEALWELL AI nutzt Orion Health für den Eintritt in den US-Markt | - HEALWELL führt eine Reihe von KI-gestützten Tools auf dem US-Markt ein, die das bestehende Softwareangebot von Orion Health in den USA ergänzen.
- Dadurch
werden die... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,745 | -2,49 % | Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline | ||
SPINEWAY | 0,118 | -1,67 % | Spineway: Minutes of the General Meeting of June 4, 2025 | Press release Ecully, June 6, 2025 - 6.00 p.m. SPINEWAY Minutes of the General Meeting of June 4, 2025 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders... ► Artikel lesen |